Valuation: Embecta Corp.

Capitalization 728M 620M 575M 540M 1.01B 66.23B 1.08B 6.63B 2.62B 31.49B 2.73B 2.67B 115B P/E ratio 2026 *
4.9x
P/E ratio 2027 * 4.71x
Enterprise value 728M 620M 575M 540M 1.01B 66.23B 1.08B 6.63B 2.62B 31.49B 2.73B 2.67B 115B EV / Sales 2026 *
0.67x
EV / Sales 2027 * 0.67x
Free-Float
98.8%
Yield 2026 *
4.87%
Yield 2027 * 4.87%
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.81%
1 week-2.92%
Current month+3.45%
1 month+4.60%
3 months-12.84%
6 months+25.66%
Current year+3.45%
More quotes
1 week 12.01
Extreme 12.01
12.86
1 month 11.38
Extreme 11.38
13.03
Current year 11.38
Extreme 11.38
13.03
1 year 9.2
Extreme 9.2
19.67
3 years 9.2
Extreme 9.2
33.88
5 years 0
Extreme 0
49
10 years 0
Extreme 0
49
More quotes
Manager TitleAgeSince
Chief Executive Officer 58 21/03/2022
Director of Finance/CFO 53 21/03/2022
Chief Tech/Sci/R&D Officer 62 30/09/2021
Director TitleAgeSince
Director/Board Member 58 31/03/2022
Director/Board Member 60 19/03/2022
Chairman 72 31/03/2022
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-0.81%-2.92%-34.21%-48.19% 728M
-0.51%-2.54%+6.75%+7.37% 211B
+1.90%+2.26%+11.94%+21.86% 126B
-1.18%+1.38%+44.88%+116.18% 68.03B
-1.80%+0.93%-14.32%-19.87% 57.95B
-0.58%-4.08%+17.27%+82.13% 53.7B
+0.07%+3.03% - - 36.74B
+1.71%+0.68%-16.18%-34.42% 27.59B
-3.97%-0.72%+23.08%+25.78% 25.32B
-2.33%-3.86%-1.13%-36.16% 23.56B
Average -0.76%+1.03%+4.23%+12.74% 63.07B
Weighted average by Cap. -0.11%+0.77%+10.39%+24.07%
See all sector performances

Financials

2026 *2027 *
Net sales 1.08B 921M 853M 802M 1.49B 98.3B 1.6B 9.85B 3.89B 46.74B 4.05B 3.97B 171B 1.08B 924M 856M 805M 1.5B 98.63B 1.61B 9.88B 3.9B 46.9B 4.06B 3.98B 171B
Net income 150M 128M 119M 111M 207M 13.66B 223M 1.37B 540M 6.49B 563M 551M 23.7B 159M 135M 125M 118M 220M 14.46B 236M 1.45B 572M 6.88B 596M 584M 25.09B
Net Debt - -
More financial data * Estimated data
Logo Embecta Corp.
Embecta Corp. is a global medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. The Company has a portfolio of marketed products, including a variety of pen needles, syringes and safety injection devices. Its pen needles are sterile, single-use, medical devices, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. It also sells safety pen needles, which have shields on both ends of the cannula that automatically deploy after the injection to help prevent needlestick exposure and injury during injection and disposal. Its traditional and safety pen needles are compatible and frequently used with pen injectors in the market. It sells sterile, single-use insulin syringes, which are used to inject insulin drawn from insulin vials. It also sells safety insulin syringes. It distributes its products through a variety of channels, including retail, hospitals and pharmacies.
Employees
1,850
More about the company
Date Price Change Volume
20/01/26 12.29 $ -0.81% 398,965
16/01/26 12.39 $ -1.67% 435,897
15/01/26 12.60 $ -1.18% 382,324
14/01/26 12.75 $ +0.71% 321,042
13/01/26 12.66 $ -1.48% 456,280

Delayed Quote Nasdaq, January 20, 2026 at 09:00 pm

More quotes
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
12.29USD
Average target price
16.67USD
Spread / Average Target
+35.61%
Consensus

Quarterly revenue - Rate of surprise